Cultured AFB Antitubercular DST Ethionamide Test
Understanding the Cultured AFB Antitubercular DST Ethionamide Test
The Cultured AFB Antitubercular DST Ethionamide Test represents a critical advancement in tuberculosis management, specifically designed to combat drug-resistant strains of this persistent infectious disease. This sophisticated diagnostic tool evaluates the effectiveness of Ethionamide, a vital second-line antitubercular medication, against Mycobacterium tuberculosis isolates obtained from patient samples.
Tuberculosis remains a significant global health concern, with drug-resistant strains posing particular challenges to effective treatment. The emergence of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) has made drug sensitivity testing an essential component of modern tuberculosis care. This test provides physicians with the precise information needed to design targeted treatment regimens that maximize therapeutic success while minimizing side effects and treatment duration.
What the Test Measures and Detects
The Cultured AFB Antitubercular DST Ethionamide Test specifically measures the sensitivity of Mycobacterium tuberculosis complex organisms to Ethionamide. This comprehensive analysis includes:
- Determination of minimum inhibitory concentration (MIC) values for Ethionamide
- Assessment of bacterial growth inhibition at various drug concentrations
- Identification of resistant, intermediate, or sensitive strain classifications
- Evaluation of cross-resistance patterns with other antitubercular drugs
Using automated fluorescent technology, the test provides highly accurate and reproducible results that guide clinical decision-making. The methodology ensures reliable detection of even low-level resistance, which is crucial for preventing treatment failure and the development of further drug resistance.
Who Should Consider This Test
This specialized test is recommended for individuals in specific clinical situations:
Patients with Suspected Drug-Resistant Tuberculosis
- Individuals showing poor response to first-line TB treatment
- Patients with persistent symptoms despite adequate therapy
- Those with known exposure to drug-resistant TB strains
- Individuals from regions with high MDR-TB prevalence
Clinical Indications and Symptoms
- Persistent cough lasting more than 3 weeks
- Unexplained weight loss and night sweats
- Recurrent fever and fatigue
- Chest pain and breathing difficulties
- Hemoptysis (coughing up blood)
- Previous TB treatment failure or relapse
Benefits of Taking the Test
Undergoing the Cultured AFB Antitubercular DST Ethionamide Test offers numerous advantages for both patients and healthcare providers:
- Personalized Treatment Planning: Enables physicians to design customized treatment regimens based on individual bacterial sensitivity profiles
- Improved Treatment Outcomes: Increases the likelihood of successful TB eradication by ensuring appropriate drug selection
- Reduced Side Effects: Helps avoid unnecessary exposure to ineffective medications and their associated adverse effects
- Cost-Effective Care: Prevents wasted resources on ineffective treatments and reduces overall healthcare costs
- Public Health Protection: Contributes to controlling TB transmission by ensuring effective treatment of infectious cases
- Advanced Technology: Utilizes automated fluorescent methodology for superior accuracy and reliability
Understanding Your Test Results
Interpreting your Cultured AFB Antitubercular DST Ethionamide Test results requires professional medical expertise, but here’s a general guide to understanding the findings:
Sensitive Result
A sensitive result indicates that the Mycobacterium tuberculosis isolate is susceptible to Ethionamide at standard therapeutic concentrations. This suggests that Ethionamide would be an effective component of your treatment regimen, and your physician can confidently include it in your therapeutic plan.
Resistant Result
A resistant result means the bacterial strain is not effectively inhibited by Ethionamide at concentrations achievable with standard dosing. In this case, your physician will need to explore alternative second-line antitubercular medications and design a treatment regimen using other effective drugs.
Intermediate Result
An intermediate result suggests partial sensitivity, where the bacteria may respond to higher drug concentrations or in combination with other medications. Your physician will carefully consider the clinical context and may use Ethionamide with caution or monitoring.
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $100 |
| Regular Price | $162 |
Test Details and Logistics
Turnaround Time: Samples accepted daily by 3:30 PM; Reports available in 21 days
Sample Type: Submit pure growth of Mycobacterium tuberculosis complex on appropriate media in sterile screw-capped container in a sealed plastic bag. Ship refrigerated OR when used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in the Laboratory from specimens already submitted will be processed for Antitubercular Sensitivity.
Pre-test Instructions: No special preparation required
Testing Method: Automated Fluorescent Technology
Nationwide Availability
We have branches across the United States, including all major metropolitan areas. Our comprehensive network ensures that patients from New York to Los Angeles, Chicago to Houston, and Phoenix to Miami have convenient access to this essential tuberculosis testing service. Our state-of-the-art laboratories maintain the highest standards of quality and accuracy.
Take Control of Your Tuberculosis Treatment
Don’t leave your tuberculosis treatment to chance. The Cultured AFB Antitubercular DST Ethionamide Test provides the critical information needed to ensure your treatment is effective and tailored to your specific infection. With drug-resistant tuberculosis becoming increasingly common, this test represents an essential tool in the fight against this persistent disease.
Ready to get started? Book your test today or call our dedicated healthcare team at +1(267) 388-9828 to schedule your appointment. Our knowledgeable staff is available to answer your questions and guide you through the testing process.
Take the first step toward effective tuberculosis management with the precision and reliability of the Cultured AFB Antitubercular DST Ethionamide Test. Your path to successful treatment begins with accurate diagnosis.
